Discordant pathology following pancreatoduodenectomy for suspected intraductal papillary mucinous neoplasm: reassessment of cyst fluid genetic analysis
Ella Sibbersen, Dhruv J Patel, Hassam A Cheema, Ralph H Hruban, C Max Schmidt · 2026
Read Discordant pathology following pancreatoduodenectomy for suspected intraductal papillary mucinous neoplasm: reassessment of cyst fluid genetic analysis by Ella Sibbersen, Dhruv J Patel, Hassam A Cheema, Ralph H Hruban, C Max Schmidt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13619322.txt.
Description
Ella Sibbersen and four colleagues present a case that questions how far genetic testing of pancreatic cyst fluid can be trusted. Their patient, a man of about seventy, had a widened main pancreatic duct but no visible mass. Early fluid checks pointed toward a mucin-producing growth called IPMN, yet the first genetic test found no mutations, so doctors chose watchful waiting.
A year later, repeat testing found KRAS and GNAS mutations, and surgeons removed the head of the pancreas. Final pathology showed only low-grade early changes in the duct lining, not the suspected IPMN at all. The authors use the mismatch to argue that molecular results must keep being checked against surgical findings. Their case shows how a test meant to sharpen decisions can also push a patient toward major surgery he may not have needed.
Catalog record
| CREATOR | Ella Sibbersen, Dhruv J Patel, Hassam A Cheema, Ralph H Hruban, C Max Schmidt |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |